12 %Headache occurred in 12% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublié 2023The Lancet. Infectious diseasesPubMeddocument de 7 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 184 / 268
12 %Headache occurred in 12% of participants as an adverse event after yellow fever vaccination.
Kenyafièvre jaunepublié 2023The Lancet. Infectious diseasesPubMeddocument de 7 observations
10 %Malaria in pregnancy (MiP) was observed in one tenth of all study participants.
Kenyapaludismepublié 2020PloS onePubMeddocument de 7 observations
21 %NTS was isolated from 21% of stool samples in the urban site in Kenya from 2006 to 2009.
Kenyanon-Typhi Salmonellaobservé 2006-2009publié 2012PloS oneeurope_pmcdocument de 9 observationsDOI 10.1371/journal.pone.0031237
13,7 %Of 19,498 tested individuals in Nandi County, 2662 tested positive for malaria, yielding a test positivity rate of 13.7%.
Kenyapaludismepublié 2024Malaria journalPubMeddocument de 16 observations
20,4 %Among adolescent girls and young women aged 13–24 in Kenya, the predicted probability of reporting sexual violence was 20.4% for those without all three protective factors and 6.0% for those with all three protective factors, based on the 2018–19 Kenya Violence Against Children & Youth Survey.
Kenyasexual violenceobservé 2018–19publié 2025AIDS and behaviorPubMeddocument de 12 observations
0,91 hazard_ratioThere was no difference in the hazard of healing between 108 HIV-positive and 108 age-matched HIV-negative men (HR 0.91, 95% CI 0.70–1.20).
KenyaVIH/sidapublié 2013PloS oneeurope_pmcdocument de 6 observations
3,66 USD_per_client_monthThe estimated economic cost per client-month on PEP was $3.66 USD for subsidized delivery.
KenyaVIH/sidapublié 2025BMC health services researchPubMeddocument de 13 observations
14 daysThe histopathology laboratory at Moi Teaching and Referral Hospital maintained an average 14-day turnaround time for cervical cancer pathology reports between 2018 and 2022.
Kenyacancer du col de l'utérusobservé 2018–2022publié 2025BMC cancerPubMeddocument de 4 observations
0,9 odds_ratioThe avidity index of anti-circumsporozoite antibodies was not associated with protection from clinical malaria in RTS,S/AS01E-vaccinated children (OR = 0.90; 95% CI: 0.49 to 1.66; p = 0.74).
Kenyapaludismepublié 2014PloS oneeurope_pmcdocument de 2 observations
Plasmodium falciparum, P. malariae and P. ovale sporozoite infections were identified with large proportion of mixed species infections in An. funestus, An. gambiae and eight cryptic rare species.
Kenyapaludismepublié 2020Scientific reportsPubMeddocument de 2 observations
404 individualsThis study followed 404 HIV-positive women who contributed 2753 quarterly examination visits.
KenyaVIH/sidapublié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 5 observations
50 %Dans une étude menée auprès d’usagers d’héroïne dans une ville côtière du Kenya, 50 % des femmes consommatrices d’héroïne s’administraient la drogue par injection.
KenyahéroïneHAL · Unilimdocument de 92 observations
14,6 %Resistance to rifampicin (RIF) among HIV-positive tuberculosis patients in Western Kenya was 14.6%.
Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations
33 deathsOf 72 maternal deaths, 33 were due to indirect causes.
Kenyaindirect causes · mortalité maternelleobservé January 01, 2009 to June 30, 2010publié 2014American journal of public health researchOpenAlexdocument de 3 observations
50 %In 2020, opioid agonist therapy and needle and syringe programmes averted between 50.0% and 66.1% of hepatitis C virus infections among people who inject drugs in Kenya.
Kenyahépatite Cobservé 2020publié 2022AIDS (London, England)PubMeddocument de 8 observations
3,8 %Pre-acquisition CD8(+) T-cell responses were associated with enhanced post-acquisition HIV-specific CD8(+) T-cell proliferation of 3.8% compared to 1.0% (P=0.03).
KenyaVIH/sidapublié 2010AIDS (London, England)europe_pmcdocument de 2 observationsDOI 10.1097/qad.0b013e3283391d40
13,7 %Overall provider-initiated testing and counselling (PITC) coverage was 13.7% among adult outpatients aged 18–39 years at six health facilities in coastal Kenya.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations
34,54 USDThe average unit cost per male sex partner (MSP) traced was $34.54.
KenyaVIH/sidapublié 2022BMC health services researchPubMeddocument de 13 observations
12 %Of the 612 teleretina assessment photos, 12% were deemed ungradable due to media opacities, poor patient cooperation, or unsatisfactory photographs.
Kenyaage-related macular degeneration · diabetic retinopathypublié 2020Middle East African journal of ophthalmologyPubMeddocument de 7 observations
15,5 %1633 (15.5%) of the 10,557 febrile patients surveyed were RDT positive for malaria.
Kenyapaludismepublié 2016Malaria journaleurope_pmcdocument de 12 observations
50,6 %Malaria parasite prevalence was highest in children below 7 years (50.6%).
Kenyapaludismeobservé 2014publié 2015Malaria journaleurope_pmcdocument de 10 observations
Malaria transmission is high in western Kenya.
Kenyapaludismepublié 2019Malaria journaleurope_pmcdocument de 2 observations
29 US dollarThe economic cost per infection case prevented by insecticide-treated bednets was US$ 29.
Kenyainfectionpublié 2002Tropical medicine & international health : TM & IHeurope_pmcdocument de 5 observationsDOI 10.1046/j.1365-3156.2002.00874.x
1,8 per_100_person-yearsThe incidence rate difference was 1.8 per 100 person-years between the standard-of-care and intervention groups.
KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 9 observations
9,9 %Cumulative lost to follow-up incidence among children and adolescents initiating antiretroviral therapy in central Kenya was 9.9% at 12 months.
KenyaVIH/sidapublié 2022AIDS research and human retrovirusesPubMeddocument de 18 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.